Donor Lung Preservation at 10°C: Clinical and Logistical Impact
Arch Bronconeumol. 2024 Jun;60(6):336-343.
doi: 10.1016/j.arbres.2024.03.021.
Epub 2024 Apr 6.
[Article in
English,
Spanish]
Authors
Mariana Gil Barturen
1
, Rosalía Laporta Hernández
2
, Antonio Romero Berrocal
3
, Marina Pérez Redondo
4
, Natalia Gómez Lozano
5
, Javier Martín López
6
, Ana Royuela Vicente
7
, Alejandra Romero Román
1
, Lucas Hoyos Mejía
1
, Silvana Crowley Carrasco
1
, David Gómez de Antonio
1
, Jose Manuel Naranjo Gómez
1
, Mar Córdoba Peláez
1
, Nuria María Novoa
1
, Jose Luis Campo-Cañaveral de la Cruz
8
Affiliations
- 1 Thoracic Surgery and Lung Transplantation Department, Hospital Universitario Puerta de Hierro-Majadahonda, Spain.
- 2 Pneumology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Spain.
- 3 Anesthesiology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Spain.
- 4 Transplant Coordination and Intensive Care Unit, Hospital Universitario Puerta de Hierro-Majadahonda, Spain.
- 5 Immunology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Spain.
- 6 Pathology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Spain.
- 7 Biostatistics Unit; Puerta de Hierro Biomedical Research Institute (IDIPHISA), CIBERESP, Madrid, Spain.
- 8 Thoracic Surgery and Lung Transplantation Department, Hospital Universitario Puerta de Hierro-Majadahonda, Spain; Universidad Europea de Madrid, Department of Medicine, Spain. Electronic address: [email protected].
Abstract
Introduction:
Cold static donor lung preservation at 10°C appears to be a promising method to safely extend the cold ischemic time (CIT) and improve lung transplant (LTx) logistics.
Methods:
LTx from November 2021 to February 2023 were included in this single institution, prospective, non-randomized study comparing prolonged preservation at 10°C versus standard preservation on ice. The inclusion criteria for 10°C preservation were suitable grafts for LTx without any donor retrieval concerns.
Primary endpoint:
primary graft dysfunction (PGD) grade-3 at 72-h. Secondary endpoints: clinical outcomes, cytokine profile and logistical impact.
Results:
Thirty-three out of fifty-seven cases were preserved at 10°C. Donor and recipient characteristics were similar across the groups. Total preservation times (h:min) were longer (p<0.001) in the 10°C group [1st lung: median 12:09 (IQR 9:23-13:29); 2nd: 14:24 (12:00-16:20)] vs. standard group [1st lung: median 5:47 (IQR 5:18-6:40); 2nd: 7:15 (6:33-7:40)]. PGD grade-3 at 72-h was 9.4% in 10°C group vs. 12.5% in standard group (p=0.440). Length of mechanical ventilation (MV), ICU and hospital stays were similar in both groups. Thirty and ninety-day mortality rates were 0% in 10°C group (vs. 4.2% in standard group). IL-8 concentration was significantly higher 6-h post-LTx in the standard group (p=0.025) and IL-10 concentration was increased 72-h post-LTx in the 10°C group (p=0.045).
Conclusions:
Preservation at 10°C may represent a safe and feasible strategy to intentionally prolong the CIT. In our center, extending the CIT at 10°C may allow for semi-elective LTx and improve logistics with similar outcomes compared to the current standard preservation on ice.
Keywords:
10°C cold storage; Cytokines; Donor lung preservation; Logistics; Lung transplantation; Prolonged static cold preservation.
Copyright © 2024 SEPAR. Published by Elsevier España, S.L.U. All rights reserved.
MeSH terms
-
Adult
-
Cold Ischemia
-
Cytokines / blood
-
Female
-
Humans
-
Interleukin-10 / blood
-
Interleukin-8 / analysis
-
Interleukin-8 / blood
-
Length of Stay / statistics & numerical data
-
Lung
-
Lung Transplantation*
-
Male
-
Middle Aged
-
Organ Preservation* / methods
-
Primary Graft Dysfunction* / prevention & control
-
Prospective Studies
-
Respiration, Artificial
-
Time Factors
-
Tissue Donors
Substances
-
Interleukin-8
-
Interleukin-10
-
Cytokines
-
CXCL8 protein, human